These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2602515)

  • 1. Drug response assessed by the Modified Maudsley Obsessive-Compulsive Inventory.
    Dominguez RA; Jacobson AF; de la Gandara J; Goldstein BJ; Steinbook RM
    Psychopharmacol Bull; 1989; 25(2):215-8. PubMed ID: 2602515
    [No Abstract]   [Full Text] [Related]  

  • 2. [Personality disorders and obsessive-compulsive disorder: critical analysis of the literature data and our studies].
    Bellino S; Barzega G; Bogetto F; Maina G; Ravizza L
    Minerva Psichiatr; 1995 Mar; 36(1):47-50. PubMed ID: 7643732
    [No Abstract]   [Full Text] [Related]  

  • 3. Postpartum obsessive compulsive disorder: a case series.
    Sichel DA; Cohen LS; Dimmock JA; Rosenbaum JF
    J Clin Psychiatry; 1993 Apr; 54(4):156-9. PubMed ID: 8486594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine treatment of obsessive-compulsive disorder.
    Turner SM; Jacob RG; Beidel DC; Himmelhoch J
    J Clin Psychopharmacol; 1985 Aug; 5(4):207-12. PubMed ID: 3894437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine treatment of obsessive-compulsive disorder: an open clinical trial.
    Liebowitz MR; Hollander E; Schneier F; Campeas R; Hatterer J; Papp L; Fairbanks J; Sandberg D; Davies S; Stein M
    J Clin Psychopharmacol; 1989 Dec; 9(6):423-7. PubMed ID: 2687337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buspirone augmentation of fluoxetine in patients with obsessive compulsive disorder.
    Jenike MA; Baer L; Buttolph L
    J Clin Psychiatry; 1991 Jan; 52(1):13-4. PubMed ID: 1988411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of drug treatment response in obsessive-compulsive disorder.
    Ravizza L; Barzega G; Bellino S; Bogetto F; Maina G
    J Clin Psychiatry; 1995 Aug; 56(8):368-73. PubMed ID: 7635854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and fluoxetine treatment of compulsive behavior disorder of adults with mental retardation.
    Bodfish JW; Madison JT
    Am J Ment Retard; 1993 Nov; 98(3):360-7. PubMed ID: 8292312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug treatment of obsessive-compulsive disorders--a comparative study of the effectiveness of clomipramine and fluoxetine].
    Volk S
    Fortschr Neurol Psychiatr; 1995 Jun; 63 Suppl 1():28-32. PubMed ID: 7635392
    [No Abstract]   [Full Text] [Related]  

  • 10. Symptoms and physiologic manifestations in obsessive compulsive patients before and after treatment with clomipramine.
    Hoehn-Saric R; McLeod DR; Zimmerli WD; Hipsley PA
    J Clin Psychiatry; 1993 Jul; 54(7):272-6. PubMed ID: 8335655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The action of chlorimipramine in obsessive-compulsive neurosis: a pilot study.
    Yaryura-Tobias JA; Neziroglu F
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):111-6. PubMed ID: 806424
    [No Abstract]   [Full Text] [Related]  

  • 13. Anafranil in obsessive compulsive neurosis.
    Wyndowe J; Solyom L; Ananth J
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):611-7. PubMed ID: 812637
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluoxetine-clomipramine interaction.
    Sternbach H
    J Clin Psychiatry; 1995 Apr; 56(4):171-2. PubMed ID: 7713858
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prospective follow-up over a 12 month period of a cohort of 155 patients with obsessive-compulsive disorder: phase III National DRT-TOC Study].
    Hantouche EG; Bouhassira M; Lancrenon S
    Encephale; 2000; 26(6):73-83. PubMed ID: 11217541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A double-blind trial of chlorimipramine and doxepin in obsessive-compulsive neurosis].
    Cui YH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Oct; 19(5):279-81. PubMed ID: 3556094
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy assessment of fluoxetine treatment of outpatients with obsessive-compulsive disorder: a preliminary report].
    Wandzel L
    Psychiatr Pol; 1997; 31(4):429-35. PubMed ID: 9527686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buspirone in obsessive-compulsive disorder.
    Maruno CA; Hart LL
    Ann Pharmacother; 1992 Oct; 26(10):1248-51. PubMed ID: 1421651
    [No Abstract]   [Full Text] [Related]  

  • 19. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
    Zohar J; Kaplan Z; Benjamin J
    J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Maudsley Obsessive-Compulsive Stimuli Set: validation of a standardized paradigm for symptom-specific provocation in obsessive-compulsive disorder.
    Mataix-Cols D; Lawrence NS; Wooderson S; Speckens A; Phillips ML
    Psychiatry Res; 2009 Aug; 168(3):238-41. PubMed ID: 19515429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.